Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Tony J. Reiman"'
Autor:
Meletios A. Dimopoulos, Joseph Mikhael, Javier de la Rubia, Thomas G. Martin, Tomas Pika, Joaquin Martinez-Lopez, Marie-Laure Risse, Sylvia Marion, Philippe Moreau, Roman Hájek, Irina Kryuchkova, Gaëlle Asset, N. S. Castro, Tony J. Reiman, Kwee Yong, Angelo Maiolino, Bradley Augustson, Sosana Delimpasi
Publikováno v:
Journal of Clinical Oncology. 39:8034-8034
8034 Background: Patients (pts) with multiple myeloma (MM) often relapse and become refractory to successive lines of therapy, warranting better treatment options. The Phase 3 IKEMA study (NCT03275285) demonstrated that isatuximab (Isa) plus carfilzo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d8af954c8a4542f6a6c53c5ab5ec1e45
https://doi.org/10.1200/jco.2021.39.15_suppl.8034
https://doi.org/10.1200/jco.2021.39.15_suppl.8034
Autor:
Tony J. Reiman, Luisa Galvis, Trisha Daigle-Maloney, Mahmoud Abdelsalam, Amanda Caissie, Stephen Graham, Maged Salem, Farah Naz, Erik Scheme, Gisia Beydaghyan, James Charles Roger Michael, Holly Anne Campbell, Angkoon Phinyomark, Joseph Ojah, Robert Thompson, Chris Purves, Erin Brooks
Publikováno v:
Journal of Clinical Oncology. 38:e21037-e21037
e21037 Background: Currently low-dose computed tomography is used for lung cancer (LC) screening, but is limited by radiation exposure, cost, and a high false detection rate (1,2). An accurate, accessible and affordable screening technology is needed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dff9c26b6767b438a1a4984a83f123d8
https://doi.org/10.1200/jco.2020.38.15_suppl.e21037
https://doi.org/10.1200/jco.2020.38.15_suppl.e21037
Autor:
Marina Mourtzakis, Grant D. Stewart, Kathryn Calder, Kathryn Sangster, Kenneth C. H. Fearon, Gerasimos Filippatos, Richard J E Skipworth, Barbara Wieland, Jay Easaw, Tony J. Reiman, Vishesh Kumar, Monica Palcic, James A. Ross, Vickie E. Baracos, Dimitris T. Kremastinos, Brian J. Pak
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 13(17)
Purpose: A tumor-derived proteolysis-inducing factor (PIF) is suggested to be a potent catabolic factor in skeletal muscle of mice and humans. We aimed to establish the clinical significance of PIF in cancer patients and to elucidate its structural f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25877c0f8b1c004157111798cde404b5
https://pubmed.ncbi.nlm.nih.gov/18381968
https://pubmed.ncbi.nlm.nih.gov/18381968